Antibacterial derivative of 7-aminocephalosporanic acid
N - (7 - 21 - thienylacetami doceph - 3 em -3 - yl methyl) - pyridinium - 4 - carboxylate is prepared by reacting a compound of formula where R is H or a 2-thienylacetyl, with pyridine in a strongly polar medium, the resulting compound where R is H, being 2-thienylacetylated. Alternatively, cephal...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | N - (7 - 21 - thienylacetami doceph - 3 em -3 - yl methyl) - pyridinium - 4 - carboxylate is prepared by reacting a compound of formula where R is H or a 2-thienylacetyl, with pyridine in a strongly polar medium, the resulting compound where R is H, being 2-thienylacetylated. Alternatively, cephalosporin C may be treated with pyridine, converted to the 7-ACA derivative, which is then 2-thienylacetylated. Compound IIa may be in the form of a water-soluble salt.ALSO:A pharmaceutical formulation for human or veterinary use comprises N-(7-21-thienyl-acetamidoceph-3-em-3yl methyl)pyridinium-4-carboxylate. The compositions may be for oral, parenteral or topical use and include a veterinary arate. Optional ingredients are antibacterial antibiotics such as penicillins and/or tetracyclines. |
---|